文献速递乳腺技术与安全US

淋巴超声造影在新辅助化疗后乳腺癌患者前哨淋巴结识别中的应用

Sentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography.
PubMed 文献 · J Ultrasound Med · 2023-01-02

本研究评估淋巴超声造影在新辅助化疗后乳腺癌手术患者中识别前哨淋巴结的效能。18例患者共切除72枚前哨淋巴结,淋巴超声造影对恶性前哨淋巴结的检出率为100%(15/15),高于蓝色染料(47%)和放射性示踪剂(67%),与放射性示踪剂准确性相似且高于蓝色染料。

要点

  • 淋巴超声造影对恶性前哨淋巴结检出率达100%,优于蓝色染料和放射性示踪剂。
  • 淋巴超声造影与放射性示踪剂准确性相似,高于蓝色染料。
  • 新辅助化疗后乳腺癌患者可考虑使用淋巴超声造影辅助前哨淋巴结识别。

核心结论

  • 淋巴超声造影识别前哨淋巴结的准确性类似于放射性示踪剂,高于蓝色染料。
  • 15枚病理恶性前哨淋巴结均被淋巴超声造影识别。

研究设计与样本

  • 18例患者术前行瘤周皮下注射Sonazoid总计1.0 mL,使用S3000 HELX超声仪线阵探头行淋巴超声造影。
  • 所有患者接受蓝色染料和放射性示踪剂作为标准治疗,切除的前哨淋巴结分别检测蓝色染料、放射性示踪剂和Sonazoid阳性情况,并与病理结果比较。

诊断标准与关键数值

  • 以蓝色染料为参考,放射性示踪剂和淋巴超声造影的准确性均为53%(P > .50)。
  • 以放射性示踪剂为参考,蓝色染料准确性为53%,淋巴超声造影准确性为67%(P < .01)。
  • 72枚前哨淋巴结中15枚病理恶性,检出率:蓝色染料47%(7/15)、放射性示踪剂67%(10/15)、淋巴超声造影100%(15/15)(P < .001)。

临床应用与阅片要点

  • 淋巴超声造影可作为新辅助化疗后乳腺癌患者前哨淋巴结定位的辅助手段。
  • 淋巴超声造影对恶性前哨淋巴结检出率高,有助于减少假阴性。

局限性

  • 新辅助化疗亚组样本量较小(18例),结果需更大样本验证。
  • 单中心研究,设备与操作者依赖性可能影响推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study evaluated the efficacy of lymphosonography in the identification of sentinel lymph nodes (SLNs) in post neoadjuvant chemotherapy patients with breast cancer scheduled to undergo surgical excision.

METHODS: Seventy-nine subjects scheduled for breast cancer surgery with SLN excision completed this IRB-approved study, out of which 18 (23%) underwent neoadjuvant chemotherapy before surgery. Subjects underwent percutaneous Sonazoid (GE Healthcare) injections around the tumor area for a total of 1.0 mL. Lymphosonography was performed using CPS on an S3000 HELX scanner (Siemens Healthineers) with a linear probe. Subjects received blue dye and radioactive tracer as part of their standard of care. Excised SLNs were classified as positive or negative for the presence of blue dye, radioactive tracer and Sonazoid. The results were compared between methods and pathology findings.

RESULTS: Seventy-two SLNs were surgically excised from 18 subjects, 29 were positive for blue dye, 63 were positive for radioactive tracer and 57 were positive for Sonazoid. Comparison with blue dye showed that both radioactive tracer and lymphosonography achieved an accuracy of 53% (P > .50). Comparison with radioactive tracer showed that blue dye had an accuracy of 53%, while lymphosonography achieved an accuracy of 67% (P < .01). Of the 72 SLNs, 15 were determined malignant by pathology; the detection rate was 47% for blue dye (7/15), 67% for radioactive tracer (10/15) and 100% for lymphosonography (15/15) (P < .001).

CONCLUSIONS: Lymphosonography achieved similar accuracy as radioactive tracer and higher accuracy than blue dye for identifying SLNs. The 15 SLNs positive for malignancy were all identified by lymphosonography.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Machado, Liu, Needleman, et al. Sentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography. J Ultrasound Med. 2023. PMID: 36591785. doi:10.1002/jum.16164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。